CompoAtlas

Nitro-Tech Hardcore Vanilla Ice Cream Milkshake

On sale on the US market (according to the DSLD)

MuscleTech, food supplement from the US market

Nitro-Tech Hardcore Vanilla Ice Cream Milkshake (MuscleTech), a food supplement au code-barres 631656800203, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.

Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.

Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.

If this product were sold in France

A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.

Label composition

Brand
MuscleTech
Barcode
631656800203
Form
Liquid
One serving
15 US fluid ounces (29.6 ml)
Servings
up to 3 servings per day
Other ingredients (in English, as written)
filtered Water, Protein Blend (Amino Acid/Protein), Cellulose Gum, Natural and Artificial flavors, Sucralose, Dipotassium Phosphate, Acesulfame-Potassium, Carrageenan, Dimethylpolysiloxane
Ingredient (as written, in English)CategoryPer serving
CaloriesOther190 Calorie(s)
Calories from FatOther10 Calorie(s)
Total FatFat1 Gram(s)
Saturated FatFat0.5 Gram(s)
Trans FatFat0 Gram(s)
CholesterolFat30 mg
Total CarbohydratesCarbohydrate7 Gram(s)
Dietary FiberFibre2 Gram(s)
SugarCarbohydrate2 Gram(s)
ProteinProtein40 g
CalciumMineral672 mg
SodiumMineral85 mg
Nitro Infusion ComplexBlend970 mg
Nitroxen:
Glutamine PeptidesAmino acidnot stated
L-GlutamineAmino acidnot stated
American Ginseng extract (Panax quinquefolius)Plantnot stated
N-Acetyl L-CysteineOther substancenot stated
Insulogen:
D-Myo InositolOther substancenot stated
TaurineOther substancenot stated
Alpha Lipoic AcidOther substancenot stated
D-PinitolOther substancenot stated
L-LeucineAmino acidnot stated
SynthePro:
L-MethionineAmino acidnot stated
L-PhenylalanineAmino acidnot stated
L-HistidineAmino acidnot stated
L-ThreonineAmino acidnot stated
L-ValineAmino acidnot stated
L-Lysine MonohydrochlorideAmino acidnot stated
L-IsoleucineAmino acidnot stated
LactoferrinProteinnot stated

Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.

This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • L-Glutamine
    Read the warning, when it applies and the studies cited

    L-Glutamine

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 30 January 2026

  • American Ginseng extract
    Read the warning, when it applies and the studies cited

    PANAX QUINQUEFOLIUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or digoxin (Brinker 2010; Dasgupta et al. 2007; Elmer et al. 2007; Yuan et al. 2004).

    Sources cited by Health Canada (4)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Dasgupta A, Kang E, Olsen M, Actor JK, Datta P. Interference of Asian, American, and Indian (Ashwagandha) ginseng in serum digoxin measurements by a fluorescence polarization immunoassay can be minimized by using a new enzyme-linked chemiluminescent immunosorbent or turbidimetric assay. Archives of Pathology & Laboratory Medicine 2007;131(4):619-621. PubMed
    • Elmer GW, Lafferty WE, Tyree PT, Lind BK. Potential interactions between complementary/alternative products and conventional medicines in a Medicare population. The Annals of Pharmacotherapy 2007;41(10):1617-1624. PubMed
    • Yuan CS, Wei G, Dey L, Karrison T, Nahlik L, Maleckar S, Kasza K, Ang-Lee M, Moss J. American ginseng reduces warfarin's effect in healthy patients. Annals of internal medicine 2004;141(1):23-27. PubMed Randomised trial

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Dascalu et al. 2007; Vuksan et al. 2000a,b,c).

    Sources cited by Health Canada (3)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Dascalu A, Sievenpiper JL, Jenkins AL, Stavro MP, Leiter LA, Arnason JT, Vuksan V. Five batches representative of Ontario-grown American ginseng root produce comparable reductions of postprandial glycemia in healthy individuals. Canadian Journal of Physiology and Pharmacology 2007;85(9):856-864. PubMed
    • Vuksan V, Xu Z, Jenkins AL, Belgan U, Sievenpiper JL, Leiter LA, Josse RG, Stavro MP.American ginseng (Panax quinquefolium L.) improves long-term glycemic control in type 2 diabetes: double-blind placebo controlled crossover trial. Diabetes 2000a;49 (Suppl.1):A95.

    Condition of application: All products except Glucose levels and Adaptogen - immune system.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

  • Taurine
    Read the warning, when it applies and the studies cited

    TAURINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).

    Sources cited by Health Canada (2)
    • López Ramón Y Cajal C, Ocampo Martínez R, Couceiro Naveira E, Martínez M. Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2007;20(3):225-231.
    • Seghieri G, Tesi F, Bianchi L, Loizzo A, Saccomanni G, Ghirlanda G, Anichini R, Franconi F. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007;76(2):187-192. PubMed

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).

Photograph the packaging

Brand : MuscleTech

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Nitro-Tech Hardcore Vanilla Ice Cream Milkshake (MuscleTech): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/631656800203-nitro-tech-hardcore-vanilla-ice-cream-milkshake-muscletech, updated 23 December 2011.

List recorded in 2011. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line